Joseph Edelman – ENGN history
- Issuer:
- ENGENE THERAPEUTICS INC
- Quarters tracked:
- 7 (Q1 2024 → Q2 2026)
- Current shares:
- 4,822,169
- Current value:
- $8.34M
- Peak shares:
- 5,869,076 (Q4 2025)
- Overall change:
- +383%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 4,822,169 | $8.34M | $1.73 | -1,005,337 | -17% |
| Q1 2026 | 5,827,506 | $39.69M | $6.81 | -41,570 | -1% |
| Q4 2025 | 5,869,076 | $53.00M | $9.03 | +3,771,840 | +180% |
| Q3 2025 | 2,097,236 | $14.32M | $6.83 | +2,097,236 | +100% |
| Q3 2024 | SOLD | — | — | -800,000 | -100% |
| Q2 2024 | 800,000 | $7.54M | $9.43 | -198,888 | -20% |
| Q1 2024 | 998,888 | $16.93M | $16.95 | — | NEW |